Glucose Directs Amyloid-beta into Membrane-active Oligomers
Overview
Chemistry
Authors
Affiliations
Oligomeric amyloid-β 1-42 (Aβ-42) peptides are considered to be the most toxic species connected to the occurrence of Alzheimer's disease. However, not all aggregation conditions promote oligomer formation in vitro, raising the question whether oligomer formation in vivo also requires a specific suitable cellular environment. We recently found that interaction with neuronal membranes initiates aggregation of Aβ-42 and neuronal uptake. Our data suggest that small molecules in the extracellular space can facilitate the formation of membrane-active Aβ-42 oligomers. We analyzed the early stage of Aβ-42 aggregation in the presence of glucose and sucrose and found that these sugars strongly favor Aβ-42 oligomer formation. We characterized oligomers by dynamic light scattering, atomic force microscopy, immuno-transmission electron microscopy and fluorescence cross correlation spectroscopy. We found that Aβ-42 spontaneously and rapidly forms low molecular weight oligomers in the presence of sugars. Slightly acidic pH (6.7-7) greatly favors oligomer formation when compared to the extracellular physiological pH (7.4). Circular dichroism demonstrated that these Aβ-42 oligomers did not adopt a β-sheet structure. Unstructured oligomeric Aβ-42 interacted with membrane bilayers of giant unilamellar vesicles (GUV) and neuronal model cells, facilitated cellular uptake of Aβ-42, and inhibition of mitochondrial activity. Our data therefore suggest that elevated concentrations of glucose within the range observed in diabetic individuals (10 mM) facilitate the formation of membrane-active Aβ-42 oligomers.
DDX50 cooperates with STAU1 to effect stabilization of pro-differentiation RNAs.
Miao W, Porter D, Siprashvili Z, Ferguson I, Ducoli L, Nguyen D Cell Rep. 2025; 44(1):115174.
PMID: 39764852 PMC: 11875220. DOI: 10.1016/j.celrep.2024.115174.
Koops E, Dutta J, Hanseeuw B, Becker J, Van Egroo M, Prokopiou P Alzheimers Dement. 2024; 21(1):e14385.
PMID: 39588792 PMC: 11772725. DOI: 10.1002/alz.14385.
Kc S, Nguyen K, Nicholson V, Walgren A, Trent T, Gollub E Elife. 2024; 13.
PMID: 39560655 PMC: 11575898. DOI: 10.7554/eLife.97231.
Hong S, Hong S, Lee S Anim Cells Syst (Seoul). 2023; 27(1):103-111.
PMID: 37033452 PMC: 10075522. DOI: 10.1080/19768354.2023.2197761.
Simple, Reliable Protocol for High-Yield Solubilization of Seedless Amyloid-β Monomer.
Taylor A, Davis P, Aubrey L, White J, Parton Z, Staniforth R ACS Chem Neurosci. 2022; 14(1):53-71.
PMID: 36512740 PMC: 9817077. DOI: 10.1021/acschemneuro.2c00411.